We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+14.7%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$26.8B
AUM Growth
+$2.91B
(+12%)
Cap. Flow
+$381M
Cap. Flow
% of AUM
1.42%
Top 10 Holdings %
Top 10 Hldgs %
30.26%
Holding
2,338
New
416
Increased
946
Reduced
559
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$80.5M |
| 2 |
Netflix
NFLX
|
+$48M |
| 3 |
Broadcom
AVGO
|
+$47.1M |
| 4 |
Palantir
PLTR
|
+$44.5M |
| 5 |
Intuitive Surgical
ISRG
|
+$41.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$62.2M |
| 2 |
Global Payments
GPN
|
+$50.1M |
| 3 |
Honeywell
HON
|
+$31.1M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$30.5M |
| 5 |
Medtronic
MDT
|
+$30.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.25% |
| 2 | Financials | 14.66% |
| 3 | Consumer Discretionary | 9.77% |
| 4 | Communication Services | 9.36% |
| 5 | Healthcare | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
AES
AES
$10.6B
| $179K | ﹤0.01% |
+16,969
| New | +$182K |
|
1702
Arcutis Biotherapeutics
ARQT
$3.42B
| $178K | ﹤0.01% |
+12,700
| New | +$178K |
|
1703
BGC Group
BGC
$5.58B
| $178K | ﹤0.01% |
17,400
-25,600
| -60% | -$235K |
|
1704
Charles River Laboratories
CRL
$10.9B
| $177K | ﹤0.01% |
+1,166
| New | +$155K |
|
1705
Morningstar
MORN
$6.56B
| $176K | ﹤0.01% |
+562
| New | +$166K |
|
1706
Albemarle
ALB
$13.5B
| $176K | ﹤0.01% |
+2,809
| New | +$166K |
|
1707
Metallus
MTUS
$873M
| $176K | ﹤0.01% |
11,400
+800
| +8% | +$10.7K |
|
1708
Murphy USA
MUSA
$11.3B
| $175K | ﹤0.01% |
+430
| New | +$195K |
|
1709
American Airlines Group
AAL
$9.58B
| $175K | ﹤0.01% |
+15,587
| New | +$167K |
|
1710
Saia
SAIA
$11.3B
| $175K | ﹤0.01% |
637
-2,330
| -79% | -$664K |
|
1711
H&R Block
HRB
$5.18B
| $174K | ﹤0.01% |
+3,169
| New | +$183K |
|
1712
ACM Research
ACMR
$5.83B
| $174K | ﹤0.01% |
6,700
+1,000
| +18% | +$22.5K |
|
1713
Vita Coco
COCO
$3.77B
| $173K | ﹤0.01% |
4,800
-9,300
| -66% | -$311K |
|
|
MZTI
1714
The Marzetti Company
MZTI
$2.94B
| $173K | ﹤0.01% |
1,000
| – | – |
|
|
NNE
1715
Nano Nuclear Energy
NNE
$813M
| $172K | ﹤0.01% |
+5,000
| New | +$138K |
|
1716
StepStone Group
STEP
$3.48B
| $172K | ﹤0.01% |
3,100
-11,400
| -79% | -$610K |
|
1717
Arvinas
ARVN
$518M
| $171K | ﹤0.01% |
+23,300
| New | +$172K |
|
1718
Medpace
MEDP
$16.8B
| $171K | ﹤0.01% |
546
-32,454
| -98% | -$9.74M |
|
1719
Ryan Specialty Holdings
RYAN
$5.41B
| $171K | ﹤0.01% |
+2,509
| New | +$173K |
|
1720
Business First Bancshares
BFST
$1.02B
| $170K | ﹤0.01% |
6,900
+500
| +8% | +$11.8K |
|
1721
Gencor Industries
GENC
$223M
| $169K | ﹤0.01% |
12,100
+900
| +8% | +$11.8K |
|
1722
First Bancorp
FBP
$4.4B
| $169K | ﹤0.01% |
8,100
-4,200
| -34% | -$82.6K |
|
1723
Toro Company
TTC
$8.93B
| $168K | ﹤0.01% |
+2,383
| New | +$169K |
|
1724
MGM Resorts International
MGM
$11.7B
| $168K | ﹤0.01% |
+4,897
| New | +$155K |
|
1725
Elanco Animal Health
ELAN
$12.4B
| $168K | ﹤0.01% |
+11,762
| New | +$137K |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q2 2025 Portfolio in Review
As of Q2 2025, STRS Ohio held 2,338 positions worth $26.8B, up 12% from $23.9B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
STRS Ohio's Q2 2025 filing shows 416 new, 946 increased, 559 reduced and 143 closed positions. Its largest new stake was Rockwell Automation: 97,205 shares worth $32.3M. The largest sale was Progressive, an estimated $62.2M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
- STRS Ohio's largest Q2 2025 buy was Rockwell Automation: 97,205 shares worth $32.3M.
- STRS Ohio added most to Microsoft in Q2 2025, an estimated $80.5M increase.
- STRS Ohio's biggest Q2 2025 reduction was Progressive, cutting an estimated $62.2M.
- STRS Ohio fully exited AstraZeneca in Q2 2025, selling an estimated $26.8M.
- STRS Ohio's ten largest holdings make up 30% of its $26.8B portfolio in Q2 2025.
- STRS Ohio opened 416 new positions and closed 143 in Q2 2025.
- STRS Ohio's portfolio value rose 12% quarter-over-quarter to $26.8B.
Based on STRS Ohio's 13F filing for Q2 2025, filed 4 Aug 2025.